Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
2.48%
0%
2.48%
6 Months
-5.14%
0%
-5.14%
1 Year
-14.71%
0%
-14.71%
2 Years
-0.61%
0%
-0.61%
3 Years
-2.0%
0%
-2.0%
4 Years
-8.67%
0%
-8.67%
5 Years
-1.77%
0%
-1.77%
Essity AB for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
2.61%
EBIT Growth (5y)
0.60%
EBIT to Interest (avg)
10.11
Debt to EBITDA (avg)
2.19
Net Debt to Equity (avg)
0.35
Sales to Capital Employed (avg)
1.15
Tax Ratio
25.52%
Dividend Payout Ratio
47.79%
Pledged Shares
0
Institutional Holding
0.20%
ROCE (avg)
12.85%
ROE (avg)
14.82%
Valuation key factors
Factor
Value
P/E Ratio
14
Industry P/E
Price to Book Value
2.18
EV to EBIT
11.85
EV to EBITDA
8.37
EV to Capital Employed
1.83
EV to Sales
1.47
PEG Ratio
0.85
Dividend Yield
3.01%
ROCE (Latest)
15.43%
ROE (Latest)
15.29%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Bullish
Bearish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bearish
Mildly Bullish
Shareholding Snapshot : Mar 2025
Shareholding Compare (%holding) 
Majority shareholders
Foreign Institutions
Domestic Funds
Held in 0 Schemes (0%)
Foreign Institutions
Held by 3 Foreign Institutions (0.2%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ
Jun'25
Mar'25
Change(%)
Net Sales
34,185.00
34,976.00
-2.26%
Operating Profit (PBDIT) excl Other Income
6,125.00
6,227.00
-1.64%
Interest
243.00
389.00
-37.53%
Exceptional Items
0.00
0.00
Consolidate Net Profit
3,053.00
3,083.00
-0.97%
Operating Profit Margin (Excl OI)
128.30%
128.10%
0.02%
USD in Million.
Net Sales
QoQ Growth in quarter ended Jun 2025 is -2.26% vs -7.48% in Mar 2025
Consolidated Net Profit
QoQ Growth in quarter ended Jun 2025 is -0.97% vs 6.57% in Mar 2025
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
145,546.00
147,147.00
-1.09%
Operating Profit (PBDIT) excl Other Income
26,344.00
24,883.00
5.87%
Interest
767.00
1,017.00
-24.58%
Exceptional Items
-908.00
-2,018.00
55.00%
Consolidate Net Profit
12,033.00
9,517.00
26.44%
Operating Profit Margin (Excl OI)
131.60%
120.60%
1.10%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is -1.09% vs 12.05% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is 26.44% vs 84.26% in Dec 2023
About Essity AB 
Essity AB
FMCG
Essity AB (publ) is a Sweden-based hygiene and health company that develops, produces, markets and sells personal care and tissue products. The Company conducts sales in about 150 countries under such brands, as TENA for incontinence products and Tork for Away-from-Home tissue, as well as under other brands, such as Bodyform, Velvet, Cushelle and Plenty. The Company’s medical brands comprise Leukoplast, Cutimed, JOBST, Delta Cast, Delta Lite and Actimove.
Company Coordinates 
Company Details
Klarabergsviadukten 63 , STOCKHOLM None : 111 64
Registrar Details






